An update from Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ( (AU:RMD) ) is now available.
ResMed Inc. has filed its quarterly report for the period ending March 31, 2025, indicating compliance with all necessary regulatory requirements. The report includes detailed financial statements and management’s discussion on the company’s financial condition and operational results. This filing underscores ResMed’s commitment to transparency and regulatory adherence, which is crucial for maintaining investor confidence and supporting its market position.
More about Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
ResMed Inc. operates in the healthcare industry, focusing primarily on the development and manufacturing of cloud-connected devices for people with sleep apnea, chronic obstructive pulmonary disease, and other respiratory conditions. The company is a leader in sleep and respiratory care, providing innovative solutions that improve the quality of life for patients worldwide.
YTD Price Performance: -1.65%
Average Trading Volume: 1,466,389
Technical Sentiment Signal: Sell
Current Market Cap: A$53.97B
See more data about RMD stock on TipRanks’ Stock Analysis page.